학술논문
Ensemble-plus Study Design: An Investigation of Shortened Ocrelizumab Infusion Time on Infusion-related Reactions in Patients with Relapsing Multiple Sclerosis from the Phase Iiib Ensemble-plus Study
Document Type
Abstract
Author
Source
In Multiple Sclerosis and Related Disorders November 2018 26:256-256
Subject
Language
ISSN
2211-0348